Australia’s botulinum toxin market expands due to growing cosmetic procedures and aging population. Demand for wrinkle reduction and aesthetic treatments rises in urban clinics. Therapeutic uses in neurology and pain management also grow. Regulatory approvals and skilled practitioners support adoption. Social media boosts awareness, driving consumer interest in treatments.
Read More: https://www.imarcgroup.com...